MR-simulation in Radiotherapy for Prostate Cancer — FIMRA-P  

Cancer of the PROSTATE Clinical Trial

Official title: An Exploratory Study to Assess the Feasibility of Incorporating MR in the Radiotherapy Pathway of Patients With Prostate Cancer

Status Active, not recruiting

Clinical Trial Summary

To assess the feasibility of acquiring an MR scan in the radiotherapy treatment position as part of the patient's radiotherapy pathway and incorporating the data into our radiotherapy planning systems, so that it can be potentially used to reduce healthy tissue exposure to radiation. Subsequently, the protocols and procedures established can be used to put the technique into routine clinical practice.

Clinical Trial Description

Conventional radiotherapy treatment planning uses computed tomography (CT) scans to provide an accurate 3-D picture of the local anatomy. This helps the planners to maximise the radiation dose delivered to the prostate, whilst minimising the dose to surrounding normal tissue. Magnetic resonance imaging (MRI) scanning is an established diagnostic imaging technique that provides even clearer images of the local anatomy. However, until recently the technology hasn't existed to allow us to perform MRI scans with patients "set-up" in the position required to plan and deliver radiotherapy to the prostate. This study is being performed to assess methods that may allow us to incorporate MRI scans into the radiotherapy planning process, which may further increase the accuracy of the treatment, reducing the irradiation of surrounding normal tissue and minimising toxicity. ;

Related Conditions & MeSH terms

• Cancer of the PROSTATE
• Prostatic Neoplasms

• NCT number: NCT03238170
• Study type: Interventional
• Source: Guy's and St Thomas' NHS Foundation Trust
• Status: Active, not recruiting
• Phase: N/A
• Start date: March 1, 2017
• Completion date: June 2023